Alembic Pharma Gains 10% After USFDA Approval for Antipsychotic Drug
Shares of Alembic Pharmaceuticals Ltd. rose by almost 10% to touch a 52-week high of Rs 1,192.75 on 24 July after the company announced securing...
Tag : USFDA approval
Alembic Pharma Shares Surge on USFDA Tentative Approval for Selexipag Injection
Shares of Alembic Pharmaceuticals rose by almost 2% to a day’s high of Rs 996.35 on 15 July, after the company received a tentative USFDA...
Alembic Pharma Secured USFDA Approval for Bromfenac Ophthalmic Solution
Alembic Pharmaceuticals Ltd on 9 July announced receiving approval from the US Food and Drug Administration (USFDA) for its Bromfenac ophthalmic solution that is used...
Glenmark Pharma Receives USFDA Approval for Edaravone Injection
Gland Pharma Ltd. announced on Tuesday that the US health government has approved its generic Edaravone injection for the treatment of amyotrophic lateral sclerosis. According...
Granules Shares Gain 2% on USFDA Approval
Shares of Granules India Ltd were trading 2% higher on 30 April after it announced receiving approval from the US health authorities to market a...
Glenmark Pharma Shares Gain 1% on Receiving USFDA Approval
Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 29 April after the company announced receiving USFDA final approval for...
Caplin Point Shares Gain 2% on USFDA Approval for Eye Treatment Drug
Shares of Caplin Point Laboratories Ltd were trading 2% higher on 16 April after the United States Food and Drug Administration (USFDA) gave its subsidiary...
Gland Pharma Shares Rally 7% on Securing USFDA Approval
Shares of Gland Pharma Ltd were trading in the green and 7% higher on 8 April after the company announced receiving USFDA approval for Eribulin...
Aurobindo Pharma Shares Rose 2% USFDA Approval for Nasal Spray
Aurobindo Pharma Limited Shares share price surged as much as 2% in the early trade on March 20 after the company received US Food &...
Zydus Lifesciences Shares Gain 3% on Launching New Cancer Drug; USFDA Approval for 2 New Injections
Shares of Zydus Lifesciences were trading 3% higher on 14 March on launching the new cancer drug Olaparib. The company has announced the launch of...